Back to VANGUARD GROUP INC VANGUARD GROUP INC

LENZLENZ
6 quarters

Position history for VANGUARD GROUP INCVANGUARD GROUP INC's holdings in LENZ THERAPEUTICS INC

As of its last 13F, for Q4 2025, Vanguard Group held 1,321,202 shares of LENZ (Lenz Therapeutics), worth $21.1M. It reduced the position by 9,084 shares (-0.7%) from Q3 2025. Vanguard Group held LENZ from Q3 2024 to Q4 2025, across 6 quarterly 13F filings.

Current Value

$21.1M

Current Shares

1.3M

Total Value Change

-$5.4M

Total Shares Change

+202,385

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q4
Latest
Decreased
1.3M
-0.7%
$21.1M0.0%$16.12
0
2025-Q3
Increased
1.3M
+3.0%
$62M0.0%$44.89
30
2025-Q2
Increased
1.3M
+7.6%
$37.8M0.0%$30.18
31
2025-Q1
Increased
1.2M
+1.8%
$30.8M0.0%$25.64
29
2024-Q4
Increased
1.2M
+5.3%
$34M0.0%$30.07
31
2024-Q3
First report
1.1M
-
$26.6M0.0%$24.04
0

Other major holders of LENZ: RA CAPITAL MANAGEMENT, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used